{"id":"W2168385579","doi":"10.1177/2040620715586528","title":"Obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia: overview and perspective","year":2015,"lang":"en","type":"review","venue":"Therapeutic Advances in Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Obinutuzumab; Medicine; Rituximab; Fludarabine; Chronic lymphocytic leukemia; Oncology; Internal medicine; Chemotherapy; Cyclophosphamide; Leukemia; Venetoclax; Immunology; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006365445,0.0006732229,0.00114761,0.002284883,0.0002132264,0.0006918118,0.0007929704,0.0009135855,0.002191911],"category_scores_gemma":[0.0006690632,0.0002344503,0.0006206786,0.00156754,0.0003335423,0.0009033835,0.0004613272,0.001696297,0.0009991113],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005184734,"about_ca_system_score_gemma":0.0007351594,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009386099,"about_ca_topic_score_gemma":0.002149395,"domain_scores_codex":[0.999827,0.00003585839,0.00002996115,0.00003028006,0.00005878598,0.00001823084],"domain_scores_gemma":[0.9996828,0.0001525009,0.00005194809,0.000005894239,0.00007694112,0.00002992297],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001247565,0.00007771664,0.0002136249,0.01732921,0.00013958,0.0002011795,0.00005859081,0.0002773498,0.001006078,0.001745111,0.02202547,0.9568013],"study_design_scores_gemma":[0.00007026518,0.0002513391,0.001437342,0.009899175,0.0003402928,0.002815424,0.00007627693,0.0001565349,0.0004595777,0.001861803,0.9826057,0.00002633432],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008678668,0.9992965,0.00004167479,0.0001771578,0.00007481458,0.000002255725,0.000007141618,0.00000327191,0.0003102315],"genre_scores_gemma":[0.0005006581,0.9989966,0.0000913268,0.0001453096,0.0000974363,0.000003479183,0.00001615426,7.353742e-7,0.0001484674],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002284883,"threshold_uncertainty_score":0.007332623,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06151108374895914,"score_gpt":0.4038393252012171,"score_spread":0.3423282414522579,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}